Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice

ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders

(2013) H. Nam et al.   HAEMATOLOGICA

Mitochondrial calcium uniporter blocker prevents cardiac mitochondrial dysfunction induced by iron overload in thalassemic mice

(2012) Sirinart Kumfu et al.   BIOMETALS

T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice

(2012) Sirinart Kumfu et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Inhibition of p38 MAPK During Ischemia, But Not Reperfusion, Effectively Attenuates Fatal Arrhythmia in Ischemia/Reperfusion Heart

(2012) Sirirat Surinkaew et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Creation of myocardial fibrosis by transplantation of fibroblasts primed with survival factors

(2011) Dong-Won Lee et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Iron overload thalassemic cardiomyopathy: Iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity

(2011) Suree Lekawanvijit et al.   CANADIAN JOURNAL OF CARDIOLOGY

Hepcidin: A novel peptide hormone regulating iron metabolism

(2011) Bhawna Singh et al.   CLINICA CHIMICA ACTA

Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria

(2011) Savitree Thummasorn et al.   MITOCHONDRION

Iron-Chelating Therapy for Transfusional Iron Overload

(2011) Gary M. Brittenham   NEW ENGLAND JOURNAL OF MEDICINE

Hepcidin and Hfe in iron overload in β-thalassemia

(2010) Sara Gardenghi et al.   Annals of the New York Academy of Sciences

β-Thalassemia Cardiomyopathy

(2010) Dimitrios T. Kremastinos et al.   Circulation-Heart Failure

T-type calcium channel as a portal of iron uptake into cardiomyocytes of beta-thalassemic mice

(2010) Sirinart Kumfu et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload

(2010) Xueshan Gao et al.   FREE RADICAL BIOLOGY AND MEDICINE

Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment

(2010) Colm J. Murphy et al.   JOURNAL OF CARDIAC FAILURE

Iron-Induced Cardiac Damage: Role of Apoptosis and Deferasirox Intervention

(2010) Y. Wang et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol

(2010) D. R. Richardson et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Efficacy of deferasirox in reducing and preventing cardiac iron overload in  -thalassemia

(2009) D. J. Pennell et al.   BLOOD

T-Type Ca 2+ Channel Blockade Prevents Sudden Death in Mice With Heart Failure

(2009) Hideyuki Kinoshita et al.   CIRCULATION

Heart rate variability in beta-thalassemia patients

(2009) Wasarut Rutjanaprom et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

The role of iron in mitochondrial function

(2008) Sonia Levi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Mitochondrial DNA Damage in Iron Overload

(2008) Xueshan Gao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

(2008) Pál Pacher et al.   Nature Protocols

Heart Rate Variability in Patients with Thalassemia Major

(2008) Firat Kardelen et al.   PEDIATRIC CARDIOLOGY